Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 115, Issue 19, Pages E4473-E4482
Publisher
Proceedings of the National Academy of Sciences
Online
2018-04-24
DOI
10.1073/pnas.1802354115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current treatment strategies for advanced prostate cancer
- (2017) Kazumasa Komura et al. INTERNATIONAL JOURNAL OF UROLOGY
- Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal Cancer
- (2017) Efrat Dotan et al. JOURNAL OF CLINICAL ONCOLOGY
- Translational Model-Based Strategy to Guide the Choice of Clinical Doses for Antibody-Drug Conjugates
- (2017) Marion Bouillon-Pichault et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA + Metastatic Colorectal Cancers
- (2017) Chengcheng Zhang et al. MOLECULAR THERAPY
- Therapeutic T cell engineering
- (2017) Michel Sadelain et al. NATURE
- Toil enables reproducible, open source, big biomedical data analyses
- (2017) John Vivian et al. NATURE BIOTECHNOLOGY
- LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics
- (2017) Holly M. Nguyen et al. PROSTATE
- SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer
- (2017) Ping Mu et al. SCIENCE
- Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
- (2017) Sheng Yu Ku et al. SCIENCE
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer
- (2016) Etienne Dardenne et al. CANCER CELL
- N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells
- (2016) John K. Lee et al. CANCER CELL
- A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors
- (2016) M. Bacac et al. CLINICAL CANCER RESEARCH
- Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas
- (2016) Brittany Kleb et al. Epigenetics
- Phage display-derived human antibodies in clinical development and therapy
- (2016) André Frenzel et al. mAbs
- Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
- (2016) Akash Kumar et al. NATURE MEDICINE
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer
- (2016) Pier-Luc Clermont et al. Clinical Epigenetics
- T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
- (2016) E. Zah et al. Cancer Immunology Research
- Cross-tissue Analysis of Gene and Protein Expression in Normal and Cancer Tissues
- (2016) Idit Kosti et al. Scientific Reports
- Antibody Drug Conjugates: Nonclinical Safety Considerations
- (2015) Mary Jane Masson Hinrichs et al. AAPS Journal
- SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer
- (2015) X. Zhang et al. CLINICAL CANCER RESEARCH
- Metastatic Poorly Differentiated Prostatic Carcinoma With Neuroendocrine Differentiation
- (2015) Partha Sarathi Chakraborty et al. CLINICAL NUCLEAR MEDICINE
- Smart CARs engineered for cancer immunotherapy
- (2015) Saul J. Priceman et al. CURRENT OPINION IN ONCOLOGY
- A fully human scFv phage display library for rapid antibody fragment reformatting
- (2015) Keyu Li et al. PROTEIN ENGINEERING DESIGN & SELECTION
- A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
- (2015) Laura R. Saunders et al. Science Translational Medicine
- Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation
- (2014) Jonathan I. Epstein et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Organoid Cultures Derived from Patients with Advanced Prostate Cancer
- (2014) Dong Gao et al. CELL
- Expression and Significance of FXYD-3 Protein in Gastric Adenocarcinoma
- (2013) Zhen-Long Zhu et al. DISEASE MARKERS
- Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
- (2013) Ali Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The Genotype-Tissue Expression (GTEx) project
- (2013) John Lonsdale et al. NATURE GENETICS
- Large-scale gene function analysis with the PANTHER classification system
- (2013) Huaiyu Mi et al. Nature Protocols
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- (2013) R. J. Brentjens et al. Science Translational Medicine
- Surfaceome Profiling Reveals Regulators of Neural Stem Cell Function
- (2013) Brian DeVeale et al. STEM CELLS
- The Basic Principles of Chimeric Antigen Receptor Design
- (2013) Michel Sadelain et al. Cancer Discovery
- Quantitative Analysis of Fission Yeast Transcriptomes and Proteomes in Proliferating and Quiescent Cells
- (2012) Samuel Marguerat et al. CELL
- Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
- (2012) Christopher C Kloss et al. NATURE BIOTECHNOLOGY
- The Raf/MEK/extracellular signal-regulated kinase 1/2 pathway can mediate growth inhibitory and differentiation signaling via androgen receptor downregulation in prostate cancer cells
- (2011) Seung-Keun Hong et al. EXPERIMENTAL CELL RESEARCH
- Independent Analysis of the Flagellum Surface and Matrix Proteomes Provides Insight into Flagellum Signaling in Mammalian-infectiousTrypanosoma brucei
- (2011) Michael Oberholzer et al. MOLECULAR & CELLULAR PROTEOMICS
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
- (2011) H. Beltran et al. Cancer Discovery
- Proteomic cell surface phenotyping of differentiating acute myeloid leukemia cells
- (2010) A. Hofmann et al. BLOOD
- Microarray analysis reveals differential expression of benign and malignant pheochromocytoma
- (2010) Jens Waldmann et al. ENDOCRINE-RELATED CANCER
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
- (2010) Maria R Parkhurst et al. MOLECULAR THERAPY
- Rank–rank hypergeometric overlap: identification of statistically significant overlap between gene-expression signatures
- (2010) Seema B. Plaisier et al. NUCLEIC ACIDS RESEARCH
- Bioinformatics construction of the human cell surfaceome
- (2009) J. P. C. da Cunha et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PredGPI: a GPI-anchor predictor
- (2008) Andrea Pierleoni et al. BMC BIOINFORMATICS
- A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies
- (2008) Lisa Berglund et al. MOLECULAR & CELLULAR PROTEOMICS
- Biotinylation reagents for the study of cell surface proteins
- (2008) Giuliano Elia PROTEOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More